2476 - 2500 of 7916 Results
Title
Year
-
OPENTitle: A Novel Variant of ATP5MC3 Associated with Both Dystonia and Spastic ParaplegiaJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 2Start Page: 375End Page: 383Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28821Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840961Citation Count: 12
-
OPENTitle: Lack of progression of beta dynamics after long‐term subthalamic neurostimulationJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 8Issue #: 11Start Page: 2110End Page: 2120Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.51463Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607445Citation Count: 20
- Mendelian Randomisation Study of Smoking, Alcohol, and Coffee Drinking in Relation to Parkinson’s Disease2021OPENTitle: Mendelian Randomisation Study of Smoking, Alcohol, and Coffee Drinking in Relation to Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 1Start Page: 267End Page: 282Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-212851Best OA location URL: https://repository.ubn.ru.nl//bitstream/handle/2066/248871/248871.pdfCitation Count: 34
-
RESTRICTEDTitle: Antimuscarinic Anticholinergic Medications in Parkinson Disease: To Prescribe or Deprescribe?Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 8Start Page: 1181End Page: 1188Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13347Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13347Citation Count: 19
- Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption2021OPENTitle: Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruptionJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-26066-5Best OA location URL: https://www.nature.com/articles/s41467-021-26066-5.pdfCitation Count: 142
- Platelet Behavior Contributes to Neuropathologies: A Focus on Alzheimer's and Parkinson's Disease2021RESTRICTEDTitle: Platelet Behavior Contributes to Neuropathologies: A Focus on Alzheimer's and Parkinson's DiseaseJournal Name: Seminars in Thrombosis and HemostasisPublisher: Georg Thieme Verlag KGVol: 48Issue #: 03Start Page: 382End Page: 404Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1055/s-0041-1733960Citation Count: 5
-
RESTRICTEDTitle: Population-specific neuromodulation prolongs therapeutic benefits of deep brain stimulationJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 374Issue #: 6564Start Page: 201End Page: 206Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/science.abi7852Citation Count: 104
-
RESTRICTEDTitle: Visual dysfunction is associated with cognitive impairment in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 22End Page: 25Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.005Citation Count: 8
- Biomarkers of neurodegeneration and glial activation validated in Alzheimer’s disease assessed in longitudinal cerebrospinal fluid samples of Parkinson’s disease2021OPENTitle: Biomarkers of neurodegeneration and glial activation validated in Alzheimer’s disease assessed in longitudinal cerebrospinal fluid samples of Parkinson’s diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 16Issue #: 10Start Page: e0257372End Page: e0257372Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0257372Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0257372&type=printableCitation Count: 29
- Direct targeting of wild-type glucocerebrosidase by antipsychotic quetiapine improves pathogenic phenotypes in Parkinson’s disease models2021OPENTitle: Direct targeting of wild-type glucocerebrosidase by antipsychotic quetiapine improves pathogenic phenotypes in Parkinson’s disease modelsJournal Name: JCI InsightPublisher: American Society for Clinical InvestigationVol: 6Issue #: 19Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1172/jci.insight.148649Best OA location URL: http://insight.jci.org/articles/view/148649/files/pdfCitation Count: 7
-
RESTRICTEDTitle: New Insights from a Two-Country Study Comparing Escalation Strategies for MS DrugsJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 19Start Page: 10End Page: 11Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000797988.61856.80Citation Count: 0
-
RESTRICTEDTitle: Then and Now: 20 Years of Monumental Strides in Movement DisordersJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 19Start Page: 8End Page: 10Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000797984.85450.f1Citation Count: 0
-
RESTRICTEDTitle: Apolipoprotein E Genotype Contributes to Motor Progression in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 196End Page: 200Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28805Citation Count: 24
-
RESTRICTEDTitle: Evaluation of Strategies for Measuring Lysosomal Glucocerebrosidase ActivityJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2719End Page: 2730Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28815Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28815Citation Count: 22
-
OPENTitle: Genetic Stratification of Age‐Dependent Parkinson's Disease Risk by Polygenic Hazard ScoreJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 62End Page: 69Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28808Best OA location URL: https://www.duo.uio.no/bitstream/10852/89465/2/Genetic%2bStratification%2bof%2bAge-Dependent%2bParkinson%2527s%2bDisease%2bRisk%2bby%2bPolygenic%2bHazard%2bScore.pdfCitation Count: 15
-
RESTRICTEDTitle: Increased functional connectivity in a population at risk of developing Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 1End Page: 6Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.09.026Citation Count: 4
- LGALS3 (galectin 3) mediates an unconventional secretion of SNCA/α-synuclein in response to lysosomal membrane damage by the autophagic-lysosomal pathway in human midbrain dopamine neurons2021OPENTitle: LGALS3 (galectin 3) mediates an unconventional secretion of SNCA/α-synuclein in response to lysosomal membrane damage by the autophagic-lysosomal pathway in human midbrain dopamine neuronsJournal Name: AutophagyPublisher: Informa UK LimitedVol: 18Issue #: 5Start Page: 1020End Page: 1048Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/15548627.2021.1967615Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15548627.2021.1967615?needAccess=trueCitation Count: 32
- A novel approach to understanding Parkinsonian cognitive decline using minimum spanning trees, edge cutting, and magnetoencephalography2021OPENTitle: A novel approach to understanding Parkinsonian cognitive decline using minimum spanning trees, edge cutting, and magnetoencephalographyJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-99167-2Best OA location URL: https://www.nature.com/articles/s41598-021-99167-2.pdfCitation Count: 2
-
OPENTitle: Fine-mapping of Parkinson’s disease susceptibility loci identifies putative causal variantsJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 31Issue #: 6Start Page: 888End Page: 900Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/hmg/ddab294Best OA location URL: https://academic.oup.com/hmg/article-pdf/31/6/888/42993647/ddab294.pdfCitation Count: 27
- Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [11C]PBR28 and Machine Learning Analysis2021OPENTitle: Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [11C]PBR28 and Machine Learning AnalysisJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 119End Page: 129Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28814Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28814Citation Count: 20
- Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome2021OPENTitle: Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette SyndromeJournal Name: JAMA Network OpenPublisher: American Medical Association (AMA)Vol: 4Issue #: 10Start Page: e2128204End Page: e2128204Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1001/jamanetworkopen.2021.28204Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2784765/jankovic_2021_oi_210819_1632849263.95.pdfCitation Count: 27
- Associations of sleep disorders with cerebrospinal fluid α-synuclein in prodromal and early Parkinson’s disease2021RESTRICTEDTitle: Associations of sleep disorders with cerebrospinal fluid α-synuclein in prodromal and early Parkinson’s diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 269Issue #: 5Start Page: 2469End Page: 2478Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-021-10812-2Citation Count: 17
- European clinical guidelines for Tourette syndrome and other tic disorders—version 2.0. Part IV: deep brain stimulation2021RESTRICTEDTitle: European clinical guidelines for Tourette syndrome and other tic disorders—version 2.0. Part IV: deep brain stimulationJournal Name: European Child & Adolescent PsychiatryPublisher: Springer Science and Business Media LLCVol: 31Issue #: 3Start Page: 443End Page: 461Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00787-021-01881-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00787-021-01881-9.pdfCitation Count: 33
-
RESTRICTEDTitle: Early‐Onset Parkinson's Disease: A Novel Deletion Comprising the DJ‐1 and TNFRSF9 GenesJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2973End Page: 2976Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28812Citation Count: 9
-
OPENTitle: T-cell based immunotherapies for Parkinson’s diseaseJournal Name: Exploration of Neuroprotective TherapyPublisher: Open Exploration PublishingVol: 1Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.37349/ent.2021.00007Best OA location URL: https://www.explorationpub.com/uploads/Article/A10047/10047.pdfCitation Count: 7